JPMorgan Chase & Co’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,136,847
Closed -$2.1M 6435
2023
Q1
$2.1M Buy
1,136,847
+886,639
+354% +$1.64M ﹤0.01% 3004
2022
Q4
$278K Buy
250,208
+141
+0.1% +$157 ﹤0.01% 4060
2022
Q3
$585K Sell
250,067
-10,503
-4% -$24.6K ﹤0.01% 3653
2022
Q2
$790K Buy
260,570
+36,186
+16% +$110K ﹤0.01% 3613
2022
Q1
$1.52M Sell
224,384
-39,509
-15% -$268K ﹤0.01% 3351
2021
Q4
$2.2M Sell
263,893
-28,532
-10% -$238K ﹤0.01% 3169
2021
Q3
$2.17M Sell
292,425
-37,878
-11% -$281K ﹤0.01% 3129
2021
Q2
$2.25M Buy
330,303
+165,028
+100% +$1.12M ﹤0.01% 3156
2021
Q1
$1.7M Buy
165,275
+43,486
+36% +$447K ﹤0.01% 3337
2020
Q4
$853K Sell
121,789
-4,018
-3% -$28.1K ﹤0.01% 3465
2020
Q3
$1.03M Sell
125,807
-9,590
-7% -$78.8K ﹤0.01% 3079
2020
Q2
$935K Sell
135,397
-15,341
-10% -$106K ﹤0.01% 3050
2020
Q1
$716K Sell
150,738
-24,199
-14% -$115K ﹤0.01% 3132
2019
Q4
$1.53M Sell
174,937
-185,828
-52% -$1.62M ﹤0.01% 2850
2019
Q3
$1.2M Buy
360,765
+65,197
+22% +$217K ﹤0.01% 2978
2019
Q2
$1.38M Buy
295,568
+15,125
+5% +$70.8K ﹤0.01% 2882
2019
Q1
$1.74M Sell
280,443
-339,705
-55% -$2.11M ﹤0.01% 2717
2018
Q4
$2.09M Buy
620,148
+180,119
+41% +$607K ﹤0.01% 2621
2018
Q3
$2.86M Buy
440,029
+266,126
+153% +$1.73M ﹤0.01% 2588
2018
Q2
$1.33M Buy
173,903
+22,488
+15% +$172K ﹤0.01% 3004
2018
Q1
$3.38M Sell
151,415
-11,308
-7% -$253K ﹤0.01% 2451
2017
Q4
$2.07M Buy
162,723
+120,523
+286% +$1.54M ﹤0.01% 2721
2017
Q3
$649K Sell
42,200
-700
-2% -$10.8K ﹤0.01% 3106
2017
Q2
$602K Sell
42,900
-64,178
-60% -$901K ﹤0.01% 3087
2017
Q1
$2.35M Buy
+107,078
New +$2.35M ﹤0.01% 2527